133 related articles for article (PubMed ID: 19669670)
1. Prostate cancer-specific anxiety in Dutch patients on active surveillance: validation of the memorial anxiety scale for prostate cancer.
van den Bergh RC; Korfage IJ; Borsboom GJ; Steyerberg EW; Essink-Bot ML
Qual Life Res; 2009 Oct; 18(8):1061-6. PubMed ID: 19669670
[TBL] [Abstract][Full Text] [Related]
2. Adaptation and validation of the memorial anxiety scale for prostate cancer (MAX-PC) in a sample of French men.
Touzani R; Mancini J; Troïan J; Bouhnik AD; Cussenot O; Gravis G; Marino P
J Patient Rep Outcomes; 2019 Sep; 3(1):60. PubMed ID: 31493106
[TBL] [Abstract][Full Text] [Related]
3. A longitudinal study on the impact of active surveillance for prostate cancer on anxiety and distress levels.
Venderbos LD; van den Bergh RC; Roobol MJ; Schröder FH; Essink-Bot ML; Bangma CH; Steyerberg EW; Korfage IJ
Psychooncology; 2015 Mar; 24(3):348-54. PubMed ID: 25138075
[TBL] [Abstract][Full Text] [Related]
4. Assessing cancer-specific anxiety in Chinese men with prostate cancer: psychometric evaluation of the Chinese version of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).
Huang Q; Jiang P; Zhang Z; Luo J; Dai Y; Zheng L; Wang W
Support Care Cancer; 2017 Dec; 25(12):3683-3690. PubMed ID: 28643193
[TBL] [Abstract][Full Text] [Related]
5. The Psychometric Properties of Taiwanese Version of the Memorial Anxiety Scale for Prostate Cancer.
Chou MC; Chien CH; Chung HJ; Chuang CK; Wu CT; Pang ST; Liu KL; Chang YH
J Pain Symptom Manage; 2021 Apr; 61(4):824-830. PubMed ID: 33198956
[TBL] [Abstract][Full Text] [Related]
6. Italian cultural adaptation of the Memorial Anxiety for Prostate Cancer scale for the population of men on active surveillance.
Alvisi MF; Repetto C; Rancati T; Badenchini F; Magnani T; Marenghi C; Villa S; Nicolai N; Salvioni R; Avuzzi B; Valdagni R; Bellardita L;
Tumori; 2018 Jun; 104(3):172-178. PubMed ID: 28623635
[TBL] [Abstract][Full Text] [Related]
7. Assessing anxiety in Black men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).
Nelson CJ; Starr TD; Macchia RJ; Hyacinthe L; Friedman S; Roth AJ
Support Care Cancer; 2016 Jul; 24(7):2905-11. PubMed ID: 26847348
[TBL] [Abstract][Full Text] [Related]
8. Extending the validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC) at the time of prostate biopsy in a racially-mixed population.
Dale W; Hemmerich J; Meltzer D
Psychooncology; 2007 May; 16(5):493-8. PubMed ID: 17080494
[TBL] [Abstract][Full Text] [Related]
9. Assessing anxiety in men with prostate cancer: further data on the reliability and validity of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).
Roth A; Nelson CJ; Rosenfeld B; Warshowski A; O'Shea N; Scher H; Holland JC; Slovin S; Curley-Smart T; Reynolds T; Breitbart W
Psychosomatics; 2006; 47(4):340-7. PubMed ID: 16844894
[TBL] [Abstract][Full Text] [Related]
10. Anxiety and distress during active surveillance for early prostate cancer.
van den Bergh RC; Essink-Bot ML; Roobol MJ; Wolters T; Schröder FH; Bangma CH; Steyerberg EW
Cancer; 2009 Sep; 115(17):3868-78. PubMed ID: 19637245
[TBL] [Abstract][Full Text] [Related]
11. Do anxiety and distress increase during active surveillance for low risk prostate cancer?
van den Bergh RC; Essink-Bot ML; Roobol MJ; Schröder FH; Bangma CH; Steyerberg EW
J Urol; 2010 May; 183(5):1786-91. PubMed ID: 20299064
[TBL] [Abstract][Full Text] [Related]
12. The memorial anxiety scale for prostate cancer: validation of a new scale to measure anxiety in men with with prostate cancer.
Roth AJ; Rosenfeld B; Kornblith AB; Gibson C; Scher HI; Curley-Smart T; Holland JC; Breitbart W
Cancer; 2003 Jun; 97(11):2910-8. PubMed ID: 12767107
[TBL] [Abstract][Full Text] [Related]
13. Determining the optimal cut-off scores for the Chinese version of the Memorial Anxiety Scale for Prostate Cancer (MAX-PC).
Huang Q; Jiang P; Ding Y; Zheng Y; Zheng L; Luo J; Dai Y; Wu F; Wang W
Health Qual Life Outcomes; 2023 Dec; 21(1):129. PubMed ID: 38041120
[TBL] [Abstract][Full Text] [Related]
14. Psychometric properties of the psychosocial screening instrument for physical trauma patients (PSIT).
Karabatzakis M; Den Oudsten BL; Gosens T; De Vries J
Health Qual Life Outcomes; 2019 Nov; 17(1):172. PubMed ID: 31718663
[TBL] [Abstract][Full Text] [Related]
15. Translation and validation of the Dutch version of the Fear of Cancer Recurrence Inventory (FCRI-NL).
van Helmondt SJ; van der Lee ML; de Vries J
J Psychosom Res; 2017 Nov; 102():21-28. PubMed ID: 28992893
[TBL] [Abstract][Full Text] [Related]
16. Item response theory analysis and properties of decisional conflict scales: findings from two multi-site trials of men with localized prostate cancer.
Pozzar RA; Berry DL; Hong F
BMC Med Inform Decis Mak; 2019 Jul; 19(1):124. PubMed ID: 31272447
[TBL] [Abstract][Full Text] [Related]
17. Long-Term Cancer Specific Anxiety in Men Undergoing Active Surveillance of Prostate Cancer: Findings from a Large Prospective Cohort.
Marzouk K; Assel M; Ehdaie B; Vickers A
J Urol; 2018 Dec; 200(6):1250-1255. PubMed ID: 29886089
[TBL] [Abstract][Full Text] [Related]
18. Cross-cultural differences in men on active surveillance' anxiety: a longitudinal comparison between Italian and Dutch patients from the Prostate cancer Research International Active Surveillance study.
Dordoni P; Remmers S; Valdagni R; Bellardita L; De Luca L; Badenchini F; Marenghi C; Roobol MJ; Venderbos LDF
BMC Urol; 2022 Jul; 22(1):110. PubMed ID: 35850672
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of the Psychometric and Structural Properties of the Spanish Version of the Hospital Anxiety and Depression Scale in Latina Cancer Patients.
Hyland KA; Hoogland AI; Gonzalez BD; Nelson AM; Lechner S; Tyson DM; Barata A; Gomez MF; Antoni MH; Small B; Meade CD; Jacobsen PB; Jim HSL
J Pain Symptom Manage; 2019 Aug; 58(2):289-296.e2. PubMed ID: 31121250
[TBL] [Abstract][Full Text] [Related]
20. Investigating the psychological impact of active surveillance or active treatment in newly diagnosed favorable-risk prostate cancer patients: A 9-month longitudinal study.
Ruane-McAteer E; Porter S; O'Sullivan J; Dempster M; Prue G
Psychooncology; 2019 Aug; 28(8):1743-1752. PubMed ID: 31243872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
